http://www.akceatx.com
Akcea Therapeutics, Inc. Company Intro
Our Commitment At Akcea, we’re on a mission to transform the treatment of unaddressed or under-addressed serious and rare diseases with leading-edge, RNA-targeted medicines. Whether you’re a patient living with a serious condition, or a physician whose patient desperately needs a therapy, we know you’re counting on us, and it fuels our unwavering commitment to … Continue reading "Home"
Industry
Healthcare
Akcea Therapeutics, Inc. Headquaters
22 Boston Wharf Road
Boston,02210
United States
Akcea Therapeutics, Inc. Share price
14 Sep 2022 08:34 GMT
$0
0.0 (0 %)
Akcea Therapeutics, Inc. Market cap
$
WMC RANKING
2023
Akcea Therapeutics, Inc. # 28
BiotechnologyLatest Akcea Therapeutics, Inc. News
05 Feb 2023
SVB Leerink Increases Ionis Pharmaceuticals (NASDAQ:IONS ...
Price T Rowe Associates Inc. MD boosted its position in shares of Ionis ... It operates through the Ionis Core and Akcea Therapeutics segments.
05 Feb 2023
Rockefeller Capital Management L.P. Sells 7270 Shares of ...
Vanguard Group Inc. raised its stake in shares of Ionis Pharmaceuticals by 0.8% ... The Akcea Therapeutics segment develops and commercializes drugs for...
05 Feb 2023
Insider Selling: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS ...
The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes...
WMC Market Score
WMC Market to Revenue Score
Akcea Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akcea Therapeutics, Inc. | USD | $336,555 | $365,071 | $-41,519 | $ | 28 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akcea Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Post vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Akcea Therapeutics, Inc. | 5.37 | 8.42 | 0.03 | 0 | 0 | 0 | 3.81 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 22 | 0 | 0 | 9.75 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.66 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
